共 32 条
- [31] RETRACTION: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study (Retraction of Vol 5, Pg 785, 2017) LANCET RESPIRATORY MEDICINE, 2024, 12 (04): : 262 - 263
- [32] Risk of incident antidepressant-treated depression associated with use of 5α-reductase inhibitors compared with use of α-blockers in men with benign prostatic hyperplasia: A population-based study using the Clinical Practice Research Datalink ( vol 37 , pg 517 , 2017) PHARMACOTHERAPY, 2024, 44 (09): : 766 - 766